PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)
Public ClinicalTrials.gov record NCT04504383. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study to Evaluate the Safety and Efficacy of Oral PN-943 in Subjects With Moderate to Severe Active Ulcerative Colitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the safety, tolerability, and clinical efficacy of PN-943 450 mg twice daily \[BID\] and PN-943 150 mg BID, compared with placebo BID, in subjects with moderate to severe active Ulcerative Colitis (UC).
Study identification
- NCT ID
- NCT04504383
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 169 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 5, 2020 (Actual)
- Primary completion
- Feb 16, 2023 (Actual)
- Completion
- Feb 16, 2023 (Actual)
- Last update posted
- Apr 25, 2023
2020 – 2023
United States locations
- U.S. sites
- 31
- U.S. states
- 17
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Protagonist Investigational Site | Tucson | Arizona | 85712 | — |
| Protagonist Investigational Site | Garden Grove | California | 92845 | — |
| Protagonist Investigational Site | Los Angeles | California | 90036 | — |
| Protagonist Investigational Site | Murrieta | California | 92563 | — |
| Protagonist Investigational Site | San Francisco | California | 94158 | — |
| Protagonist Investigational Site | Colorado Springs | Colorado | 80907 | — |
| Protagonist Investigational Site | Kissimmee | Florida | 34741 | — |
| Protagonist Investigational Site | Miami | Florida | 33125 | — |
| Protagonist Investigational Site | Miami | Florida | 33175 | — |
| Protagonist Investigational Site | Miami | Florida | 33180 | — |
| Protagonist Investigational site | Orlando | Florida | 32819 | — |
| Protagonist Investigational Site | Saint Augustine | Florida | 32086 | — |
| Protagonist Investigational Site | Wesley Chapel | Florida | 33544 | — |
| Protagonist Investigational Site | Metairie | Louisiana | 70006 | — |
| Protagonist Investigational Site | Glen Burnie | Maryland | 21061 | — |
| Protagonist Investigational Site | Chesterfield | Michigan | 48047 | — |
| Protagonist Investigational Site | Troy | Michigan | 48098 | — |
| Protagonist Investigational Site | Jackson | Mississippi | 39216 | — |
| Protagonist Investigational Site | St Louis | Missouri | 63110 | — |
| Protagonist Investigational Site | Englewood | New Jersey | 07631 | — |
| Protagonist Investigational Site | North Massapequa | New York | 11758 | — |
| Protagonist Investigational Site | Charlotte | North Carolina | 28210 | — |
| Protagonist Investigational Site | Norman | Oklahoma | 73071 | — |
| Protagonist Investigational Site | Oklahoma City | Oklahoma | 73103 | — |
| Protagonist Investigational Site | Orangeburg | South Carolina | 29118 | — |
| Protagonist Investigational Site | Nashville | Tennessee | 37212 | — |
| Protagonist Investigational Site | Austin | Texas | 78742 | — |
| Protagonist Investigational site | Garland | Texas | 75044 | — |
| Protagonist Investigational Site | Pasadena | Texas | 77505 | — |
| Protagonist Investigational Site | Spring | Texas | 77388 | — |
| Protagonist Investigational site | Lynchburg | Virginia | 24502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 91 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04504383, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 25, 2023 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04504383 live on ClinicalTrials.gov.